Please login to the form below

Not currently logged in
Email:
Password:

Bedford Laboratories

This page shows the latest Bedford Laboratories news and features for those working in and with pharma, biotech and healthcare.

Hikma pays $2.6bn for Boehringer’s US generics unit

Hikma pays $2.6bn for Boehringer’s US generics unit

The latest deal in the sector comes just over a year after Boehringer sold its troubled sterile injectables subsidiary Bedford Laboratories to Hikma in a deal valued at $300m. ... Hikma also gained ownership of Bedford's portfolio of 84 generic

Latest news

  • Boehringer planning job cuts in Germany Boehringer planning job cuts in Germany

    Bedford Laboratories to Hikma.

  • Boehringer sells injectables business to Hikma for $300m Boehringer sells injectables business to Hikma for $300m

    Bedford Laboratories is part of troubled Ben Venue division. Boehringer Ingelheim has sold troubled sterile injectables subsidiary Bedford Laboratories to Hikma Pharmaceuticals in a deal valued at $300m. ... US-based Bedford, part of Boehringer's Ben

  • Otsuka files new TB candidate in Japan as shortages worsen Otsuka files new TB candidate in Japan as shortages worsen

    Rifampin shortage. On the downside, Pfizer and Bedford Laboratories have said manufacturing problems are affecting supplies of rifampin, which remains a cornerstone of TB therapy despite being launched several decades ago. ... In Bedford's case, the

  • FDA says approval of generic Doxil will ease cancer drug shortage FDA says approval of generic Doxil will ease cancer drug shortage

    These issues have also affected other cancer drugs, including methotrexate, versions of which are made by Mylan, Sandoz, Hospira and Bedford Laboratories. ... Janssen said it was working with the FDA to gain approval for this new manufacturing process

  • MS treatment hopes

    USA. Levetiracetam. (Dr. Reddy's Laboratories). Epilepsy. USA . Lithium. (Glenmark Generics). Bipolar Disorders. ... Silodosin. Urief (Daiichi-Sankyo and Kissei Pharmaceutical). Dysuria. Japan. Sumatriptan. (Bedford Laboratories).

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Latest appointments

  • Huntingdon Life Sciences appoints Joseph Bedford Huntingdon Life Sciences appoints Joseph Bedford

    Huntingdon Life Sciences and Harlan Laboratories have appointed Joseph Bedford as corporate vice president for global strategic marketing. ... development. Dr Adrian Hardy, chief operating officer at Huntingdon Life Sciences and Harlan Laboratories, said:

  • Par hires Antonio Pera as commercial head Par hires Antonio Pera as commercial head

    His positions prior to joining JHP include senior VP, supply chain management at AmerisourceBergen Corporation, and senior management positions at Fresenius Kabi Pharmaceuticals, Oakwood Laboratories and Bedford Laboratories.

More from appointments
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...

Latest intelligence

Empowered patients: shaking the foundations of healthcare
Precision medicine represents a new paradigm in healthcare.This new approach to treating and preventing disease views the patient holistically, analysing their genes, environment and lifestyle, and using this information to...
A uniquely English genomic medicine service
The UK National Health Service is developing one standardised approach to embedding precision medicine across the whole of England. Blue Latitude Health speaks to Dr Tom Fowler, Deputy Chief Scientist...
Blended Intelligence
Data is the most valued commodity of the modern world. For P&P it's all about the application....

Infographics